Burlingame, CA, United States of America

Humanigen, Inc.


USPTO Granted Patents = 6



Trademarks = 1

Forward Citations = 4

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Cameron Durrant (5 out of 7 patents)

silverMedal Dale Chappell (4 out of 5 patents)

bronzeMedal Christopher Robert Bebbington (1 out of 44 patents)

4 Kenneth R Luehrsen (1 out of 1 patent)

5 Geoffrey T Yarranton (1 out of 28 patents)

6 Dale Chappell (1 out of 2 patents)

7 Saad J Kenderian (1 out of 4 patents)

8 Rosalie M Sterner (1 out of 1 patent)

9 Michelle J Cox (1 out of 2 patents)

10 Reona Sakemura (1 out of 1 patent)

11 Christina Yi (2 patents)

12 Andrew Mark Scott (3 patents)

13 Carmelina Murone (1 patent)

14 Catherine To (1 patent)

15 David M Martinez (27 patents)


6 patents:

Humanigen, Inc. is a clinical-stage biopharmaceutical company focused on developing cutting-edge immunotherapies for unmet needs in oncology and infectious diseases. Their lead product candidate, lenzilumab, is being evaluated for the treatment of cytokine storm associated with COVID-19. Humanigen is committed to advancing innovative therapies to improve the lives of patients worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

6 Patents

#40 in Burlingame, CA

#10,535 in California

#44,871 in US

Burlingame, CA (US)
Burlingame, CA, United States of America
Forward Citations = 4

10 inventors:

Please report any incorrect information to [email protected]
Loading…